- Sargis RM, Davis AM. Evaluation and treatment of male hypogonadism. JAMA. 2018;319(13):1375–1376. doi:10.1001/jama.2018.3182.
- Hassan J, Barkin J. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy. Can J Urol. 2016;23(Suppl 1):20–30.
- Clomid (Clomiphene Citrate) [Package Insert]. Bridgewater, NJ: Sanofi-Aventis US LLC; 2012.
- Martin-Malo A, Benito P, Castillo D, et al. Effect of clomiphene citrate on hormonal profile in male hemodialysis and kidney transplant patients. Nephron. 1993;63(4):390–394. doi:10.1159/000187240.
- Ribeiro RS, Abucham J. Clomiphene fails to revert hypogonadism in most male patients with conventionally treated nonfunctioning pituitary adenomas. Arq Bras Endocrinol Metab. 2011;55(4):266–271. doi:10.1590/S0004-27302011000400005.
- Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J Urol. 2014;192(3):875–879. doi:10.1016/j.juro.2014.03.089.
- Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med. 2013;10(6):1628–1635. doi:10.1111/jsm.12116.
- Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110(4):573–578. doi:10.1111/j.1464-410X.2011.10702.x.
- Chandrapal JC, Nielson S, Patel DP, et al. Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels. BJU Int. 2016;118(6):994–1000. doi:10.1111/bju.13546.
- Wheeler KM, Smith RP, Kumar RA, Setia S, Costabile RA, Kavoussi PK. A comparison of secondary polycythemia in hypogonadal men treated with clomiphene citrate versus testosterone replacement: a multi-institutional study. J Urol. 2017;197(4):1127–1131. doi:10.1016/j.juro.2016.10.068.
- Moskovic DJ, Katz DJ, Akhavan A, Park K, Mulhall JP. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int. 2012;110(10):1524–1528. doi:10.1111/j.1464-410X.2012.10968.x.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
Case Studies
Clomiphene for hypogonadism complicated by polycythemia
Roshirl FranciscoTexas Tech University Health Sciences Center School of Medicine, Lubbock, Texas; Correspondence[email protected]
http://orcid.org/0000-0002-5710-2011
, BA http://orcid.org/0000-0002-5710-2011, Sarah JaroudiTexas Tech University Health Sciences Center School of Medicine, Lubbock, Texas; http://orcid.org/0000-0003-2737-4128
, BS http://orcid.org/0000-0003-2737-4128, , MD, , PharmD, , MD & Alan N. PeirisTexas Tech University Health Sciences Center School of Medicine, Lubbock, Texas; ;Department of Internal Medicine, Texas Tech University Health Sciences Center Clinical Research Institute, Lubbock, Texas; http://orcid.org/0000-0001-9323-7557
, MD, PhD http://orcid.org/0000-0001-9323-7557